Mueller, L.; Engelbertz, C.; Reinecke, H.; Freisinger, E.; Malyar, N.M.; Meyborg, M.; Brix, T.J.; Varghese, J.; Gebauer, K.
Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence. J. Clin. Med. 2022, 11, 6838.
https://doi.org/10.3390/jcm11226838
AMA Style
Mueller L, Engelbertz C, Reinecke H, Freisinger E, Malyar NM, Meyborg M, Brix TJ, Varghese J, Gebauer K.
Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence. Journal of Clinical Medicine. 2022; 11(22):6838.
https://doi.org/10.3390/jcm11226838
Chicago/Turabian Style
Mueller, Linda, Christiane Engelbertz, Holger Reinecke, Eva Freisinger, Nasser M. Malyar, Matthias Meyborg, Tobias J. Brix, Julian Varghese, and Katrin Gebauer.
2022. "Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence" Journal of Clinical Medicine 11, no. 22: 6838.
https://doi.org/10.3390/jcm11226838
APA Style
Mueller, L., Engelbertz, C., Reinecke, H., Freisinger, E., Malyar, N. M., Meyborg, M., Brix, T. J., Varghese, J., & Gebauer, K.
(2022). Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence. Journal of Clinical Medicine, 11(22), 6838.
https://doi.org/10.3390/jcm11226838